Clin2
NCT06893133Possibly a fitRecruiting

DNA testing after gastric cancer surgery

Gastric Cancer

Part of Cancer, Digestive system clinical trials.

This study checks if a blood test can find leftover cancer DNA after stomach cancer surgery. It helps doctors know if more treatment is needed.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
110 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Had chemotherapy before surgery and then surgery to remove all visible cancer
  • Cancer was stage II or III at the time of surgery
  • Can provide tissue samples from before or during surgery
  • Willing to give blood samples and attend follow-up visits

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07268469Not yet recruiting
Tiny cancer DNA in blood after surgery for solid tumors

This study looks at tiny amounts of cancer DNA left in the blood after surgery for solid tumors. It aims to understand how well surgery works and if more treatment is needed.

NCT07026240Recruiting
Post-operative monitoring study for gastric cancer

This study monitors people after surgery for gastric cancer. It checks how patients recover and helps doctors learn more about the condition. You can join if you have stomach discomfort and are receiving care at the gastric surgery clinic of this center.

Shanghai, Shanghai Municipality
NCT07660627Recruiting
ctDNA test for tracking cancer after treatment

This trial uses a blood test to find tiny bits of tumor DNA after treatment. It helps doctors see if any cancer remains, which could guide next steps for people with esophageal, stomach, or pancreatic cancer.

Brno
NCT07517107Recruiting· Phase 2
Blood tests to guide gastric cancer treatment decisions

This study uses special blood tests to detect cancer DNA and help doctors decide the best treatment plan for gastric cancer. The goal is to improve outcomes by personalizing therapy based on how your cancer responds.

Shanghai
NCT05956847Recruiting
Studying DNA fragments in stomach cancer tissue

This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.

Xi'an, Shaanxi
NCT07034742Recruiting· Early Phase 1
MRD testing after stomach cancer surgery

This study looks at whether a blood test for leftover cancer cells (called MRD) after stomach cancer surgery can help guide treatment. It is for people with a certain type of stomach cancer that has spread to nearby tissues but not to distant organs, and who are having surgery as their first treatment.

Beijing

Hear when a new Gastric Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.